Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Australia dialysis equipment market was valued at USD 528.70 Million in 2025 and is expected to grow at a CAGR of 3.10%, reaching USD 717.46 Million by 2035. The market is primarily driven by rising prevalence of chronic kidney disease (CKD), an aging population, and government support for renal replacement therapies.
Base Year
Historical Period
Forecast Period
Factors like diabetes, hypertension, and an aging population are contributing to the increased prevalence of CKD, which in turn drives the demand for dialysis equipment.
Australia has an aging population, and older individuals are more susceptible to developing kidney-related diseases.
The Australian government provides significant support for renal replacement therapies like dialysis through initiatives like the Medicare Benefits Schedule (MBS) and the National Dialysis and Transplantation Outcomes (NDTO) program.
Compound Annual Growth Rate
3.1%
Value in USD Million
2026-2035
*this image is indicative*
Dialysis equipment plays a crucial role in managing chronic kidney disease (CKD) and supporting patients with kidney failure. These devices, including hemodialysis machines, peritoneal dialysis systems, and related accessories, help filter waste and excess fluids from the blood when the kidneys can no longer perform this function. Hemodialysis machines, used in clinical settings and for home dialysis, remove toxins from the blood using an external filter. Peritoneal dialysis involves infusing a special solution into the abdomen to remove waste. Advancements in dialysis equipment, such as portable devices and improved filters, are enhancing patient comfort and treatment effectiveness.
Government Support Driving Dialysis Equipment Market Growth in Australia
The Australian government’s strong backing for renal replacement therapies is a key driver of growth in the country’s dialysis equipment market. Through the Medicare Benefits Schedule (MBS), patients gain financial access to dialysis services, including provisions such as Item 13104, which reimburses up to 85% of the cost for home dialysis planning and management by a consultant physician. Similarly, Item 13105 extends coverage for remote dialysis services, expanding treatment access to patients in very remote regions. Furthermore, the National Dialysis and Transplantation Outcomes (NDTO) program, managed by the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), leverages data-driven insights to enhance care quality and policy decisions. These initiatives not only improve patient accessibility and outcomes but also create a favorable environment for the adoption and expansion of dialysis equipment across the country.
Some key trends include a factors like age related chronic illnesses and Australia’s aging population.
Increased Prevalence of CKD to Boost Dialysis Equipment Market Growth in Australia
The rising prevalence of chronic kidney disease (CKD) in Australia is expected to significantly drive demand for dialysis equipment. Diabetes (particularly type 2 diabetes) remains the leading cause of CKD in the country, and the Australian Institute of Health and Welfare (AIHW) identifies it as the primary reason patients progress to dialysis or kidney transplantation. Persistent high blood glucose levels often result in diabetic nephropathy, accelerating the need for renal replacement therapies. In 2021, more than 1.3 million Australians were diagnosed with diabetes, with a considerable share developing kidney-related complications. This growing patient pool is projected to fuel the adoption of dialysis systems and devices, as individuals with both diabetes and kidney failure face higher mortality risks, underscoring the critical role of effective dialysis equipment in improving outcomes.
Rising Aging Population to Boost Australia Dialysis Equipment Market Demand
In Australia, the aging population significantly contributes to the rising prevalence of chronic kidney disease (CKD). Data from the Australian Institute of Health and Welfare (AIHW) revealed that by 2066, the older population will make up around 21%-23% of the total population. This trend is attributed to the cumulative effects of risk factors such as hypertension, diabetes, and obesity over time. As life expectancy increases, a larger segment of the population is living with conditions that predispose them to CKD, necessitating enhanced healthcare strategies to address this growing concern.
Hemodialysis to Lead the Market by Type
Hemodialysis is the leading dialysis modality in Australia, accounting for approximately 70% of all dialysis treatments. This preference is attributed to its long-established infrastructure, including specialized clinics and trained personnel, which provide consistent and reliable care. The Australian government's support through Medicare ensures accessibility, making in-center hemodialysis the most common choice for patients with end-stage renal disease. While home dialysis options like peritoneal dialysis are growing, they still represent a smaller portion of the market. The dominance of hemodialysis reflects its entrenched role in Australia's renal care system.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Fresenius Medical Care is the world's leading provider of dialysis products and services, catering to individuals with chronic kidney failure. The company operates over 4,000 dialysis clinics globally and manufactures a comprehensive range of dialysis equipment, including machines, dialyzers, and related disposables. In Australia, Fresenius Medical Care has been serving patients undergoing dialysis for chronic kidney failure for more than a decade, offering innovative dialysis products and therapies to improve patient care. The company's commitment to quality and patient-centered care makes it a key player in the Australian dialysis equipment market.
Baxter Healthcare Pty Ltd, a subsidiary of Baxter International, has been a significant player in Australia's healthcare sector since 1963. With a manufacturing plant in Western Sydney and distribution facilities across multiple states, Baxter has a strong presence in the Australian market. In the realm of renal care, Baxter offers a comprehensive range of dialysis products and services, including the AK 98 Hemodialysis Machine and the HOMECHOICE Automated Peritoneal Dialysis (APD) system. These products are designed to enhance patient care in both hospital and home settings. Baxter's commitment to quality and innovation is evident in its extensive support network, which includes state-of-the-art Technical Service Centres throughout Australia.
B. Braun Melsungen AG is a prominent German medical and pharmaceutical device company, founded in 1839 and headquartered in Melsungen, Germany. With over 64,000 employees across more than 60 countries, B. Braun is recognized for its extensive portfolio of healthcare products and services, including dialysis equipment, infusion therapy, and surgical instruments. In Australia, B. Braun is a significant player in the dialysis equipment market. It held a substantial share of the Australian dialysis machines market, ranking second after Fresenius Medical Care. The company's offerings in Australia include advanced dialysis machines such as the Dialog system, designed for chronic hemodialysis treatments. This system features a user-friendly interface, real-time therapy analysis, and customizable treatment profiles to meet individual patient needs.
Nipro Corporation, established in 1954 and headquartered in Osaka, Japan, is a global leader in the medical equipment industry, specializing in renal care, vascular, and infusion therapy products. With over 30,000 employees worldwide, Nipro operates a comprehensive manufacturing and distribution network, including Nipro Australia, which serves as a key hub for the Asia-Pacific region. In Australia, Nipro offers a broad range of dialysis solutions, including the Surdial X hemodialysis system, which provides flexible and individualized treatments with features like step-by-step guidance and adjustable programs.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Key players include Nikkiso Co., Ltd., Asahi Kasei Corporation, and Toray Medical Co., Ltd., among others.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by End User
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share